A case of a patient with chronic headache. Focus on Migraine. None related to the presentation Grants to conduct clinical trials from: Speaker bureau:

Similar documents
Headache Master School Japan-Osaka 2016 (HMSJ-Osaka2016) October 23, II. Management of Refractory Headaches

I have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation.

Disclosures. Triptans for Kids 5/16/13

How do we treat migraine? New SIGN Guidelines

Outpatient Headache Care Guideline

Imitrex for ocular migraines

Case Presentation. Case Presentation. Case Presentation. Truths about Headaches (2017) Most headaches were muscle-tension headaches

MIGRAINE UPDATE. Objectives & Disclosures. Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment.

Jessica Ailani MD FAHS Director, Georgetown Headache Center Associate Professor Neurology Medstar Georgetown University Hospital

OH, MY ACHING HEAD! I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE MANAGING HEADACHE IN THE OUTPATIENT SETTING SECONDARY HEADACHES

Migraine: Past, Present and Future Edward O Sullivan September 12 th 2015 Dublin 12/09/2015

ปวดศ รษะมา 5 ป ก นยาแก ปวดก ย งไม ข น นพ.พาว ฒ เมฆว ช ย โรงพยาบาลนครราชส มา

Chronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary

Faculty Disclosure. Karen L. Bremer, MD. Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest.

ADVANCES IN MIGRAINE MANAGEMENT

Adult & Pediatric Patients. Stanford Health Care, Division Pain Medicine

Migranal Nasal Spray. Migranal Nasal Spray (dihydroergotamine) Description

Disclosures. Objectives 6/2/2017

An Overview of MOH. ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California

Regulatory Status FDA approved indication: Migranal Nasal Spray is indicated for the acute treatment of migraine headaches with or without aura (1).

By Nathan Hall Associate Editor

MIGRAINE CLASSIFICATION

MIGRAINE A MYSTERY HEADACHE

10/31/2017 PRIMARY CARE AND HEADACHE DISCLOSURES WHERE DO THOSE WITH HEADACHE SEEK MEDICAL CARE? Primary Care 67%

Headache Mary D. Hughes, MD Neuroscience Associates

Ishaq Abu Arafeh Consultant Paediatrician Royal Hospital for Children, Glasgow Forth Valley Royal Hospital, Larbert

Index. Prim Care Clin Office Pract 31 (2004) Note: Page numbers of article titles are in boldface type.

Faculty Disclosures. Learning Objectives. Acute Treatment Strategies

Chronic Daily Headaches

Strategies in Migraine Care

10/17/2017 CHRONIC MIGRAINES BOTOX: TO INJECT OR NOT INJECT? IN CHRONIC MIGRAINE PROPHYLAXIS OBJECTIVES PATIENT CASE EPIDEMIOLOGY EPIDEMIOLOGY

Management of headache

Understanding Migraines and Treatment Options. Simplified Diagnosis of Migraine. Migraine Prevalence American Migraine Study II

Current Migraine Treatment Therapy. Daniel Kassicieh, DO, FAAN

Headache A Practical Approach

Çiçek Wöber-Bingöl HEADACHE UNIT FOR CHILDREN AND ADOLESCENCE

Page: 1 of 5. Sumatriptan Tablets and Nasal Spray (Imitrex) / sumatriptan and naproxen sodium (Treximet tablets)

Migraine Management. Jane Melling Headache nurse Mater Misericordiae Hospital

Pharmacy Medical Necessity Guidelines: Migraine Medications

UCNS Course A Review of ICHD-3b

Paediatric headaches. Dr Jaycen Cruickshank Director of Clinical Training Ballarat Health Services. Brevity, levity, repetition

Risk Factors, Clinical Course, and Barriers to Care in Adults and Pediatrics. Rebecca R. Buttaccio, PA-C Dent Neurologic Institute

Headache. Section 1. Migraine headache. Clinical presentation

Headache Questionnaire

Headaches in the Pediatric Emergency Dept

MEASURE #4: Overuse of Barbiturate Containing Medications for Primary Headache Disorders Headache

Clinical case. Clinical case 3/15/2018 OVERVIEW. Refractory headaches and update on novel treatment. Refractory headache.

Page: 1 of 6. Aimovig (erenumab-aooe) injection, Ajovy (fremanezumab-vfrm) injection, Emgality (galcanezumab-gnim)

Specific Objectives A. Topics to be lectured and discussed at the plenary sessions

Differentiating Migraine from Other Headache Types to Target Treatment Peter J. Goadsby, MD, PhD

A synopsis of: Diagnosis and Management of Headaches in Adults: A national clinical guideline. Scottish intercollegiate Guidelines Network SIGN

Migraine, Tension, and Cluster Headache: Primary Care for Primary Headaches. Jonathon M. Firnhaber, MD, FAAFP

25/09/2018 HEADACHE. Dr Nick Pendleton

Understanding. Migraine. Amy, diagnosed in 1989, with her family.

Pearls in Child Neurology. Edgard Andrade, MD, FAAP Assistant Professor University of Florida

Pediatric Headache Diary

Update on Diagnosis and Management of Migraines

Headache evaluation and management after concussion. Assistant Professor

HEADACHE. Dr Nick Pendleton. September Headache

Triptans Quantity Limit Program Summary

Headache Assessment In Primary Eye Care

Zomig. Zomig / Zomig-ZMT (zolmitriptan) Description

Headache Pain Generators

MEASURE #3: PREVENTIVE MIGRAINE MEDICATION PRESCRIBED Headache

Vestibular Migraine. Information for patients and carers. Department of Neurology and Otolaryngology Aberdeen Royal Infirmary

Migraine Types and Triggering Factors in Children

Maxalt. Maxalt / Maxalt-MLT (rizatriptan) Description. Section: Prescription Drugs Effective Date: April 1, 2016

HEADACHE: Benign or Severe Dr Gobinda Chandra Roy

The Pediatric Headache Handbook

Neurological Dilemmas in Primary Care

Prevention and Treatment of Migraines CAITLIN BARNES, PHARM.D. CANDIDATE AMBULATORY CARE JOE CAMMILLERI, PHARM.D. NATOHYA MALLORY, PHARM.D.

1. On how many days in the last 3 months did you miss work or school because of your headaches?

Headache and Facial Pain. Mohammed ALEssa MBBS, FRCSC Assistant Professor Consultant Otolaryngology,Head & Neck Surgical Oncology

Migraine Migraine Age Specific Prevalence in the United States. Headache International Headache Society Classification

Headaches in Children and Adolescents. Paul Shillito

MEASURE #1: MEDICATION PRESCRIBED FOR ACUTE MIGRAINE ATTACK Headache

Zomig. Zomig / Zomig-ZMT (zolmitriptan) Description

Migraine Management. Roger Cady, MD Headache Care Center Springfield, MO

How could I be having migraine when I don't have a headache?

Triptan Quantity Limit

Headache. Karen Thaxter

Clinical Learning Days November 10, 2017

Managing Headache in Acute Medicine. Ben Lovell Consultant Physician in Acute Medicine University College London Hospital

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Treatments for migraine

Sumatriptan Injection (Imitrex / Alsuma / Sumavel / Zembrace)

6/4/2018. Headache. Headaches. Headache. Migraine Headaches. Headache. Red Flag signs and symptoms. Imaging CT without contrast.

Headache Classifica-on

9/2/2010. Pediatric Headache: Learning Objectives: Learning Objectives: Lynn Clark RN, PNP-BC Alicia Haag RN, FNP-C. Objective 7:

Drug List. Improving Outcomes in Episodic Migraine. Presenter Disclosure Information. Learning Objectives. Improving Outcomes in Episodic Migraine

June National Migraine and Headache Awareness Month

GENERAL APPROACH AND CLASSIFICATION OF HEADACHES

SIGN on the pharmacological management of migraine

Overuse of barbiturate and opioid containing medications for primary headache disorders Description

Daniel Kassicieh, DO, FAAN

Farjam Farzam, M.D. Pediatric Neurology

Subject: CGRP Inhibitors

Background. Background. Headache Examination. Headache History. Primary vs. Secondary Headaches. Headaches In Children: Why Worry?

Clinical Policy: Triptans Reference Number: CP.CPA.217 Effective Date: Last Review Date: Line of Business: Commercial

Headaches. Mini Medical School. November 10, A. Laine Green MSc, MD FRCP(C) Assistant Professor Department of Medicine (Neurology)

Transcription:

Chronic Daily Headache Bassel F. Shneker, MD, MBA Associate Professor Vice Chair, OSU Neurology The Ohio State University Wexner Medical Center Financial Disclosures None related to the presentation Grants to conduct clinical trials from: UCB Pharma, GSK, Eisai, Upsher-smith, Vertex, Sunovion, Pfizer Speaker bureau: Supernus Outline A case of a patient with chronic headache Chronic Daily headache h Focus on Migraine Clinical Presentation (1) 30 Y/O woman with history of depression 5 year history of almost 24/7 headache Reported holocephalic pressure (band-like) headache Intensity 5/10 but can get up to 10/10 Reported nausea and photophobia sometimes No other associated neurological symptoms Reported using acetaminophen daily 1

Clinical Presentation (2) Tried many OTCs, prescribed analgesics, a triptan, 2 antidepressants, a beta blocker, 2 AEDs, 2 muscle relaxants Reported many headache related ED visits annually Normal neurological exam (no papilledema) Normal brain MRI 2 women in family have headaches Diagnosis & Treatment? Simple Chronic daily headache (tension headache)! Start a pharmacological treatment she has not tried! Is that it? Clues to a Detailed History Fluctuation of pain severity Associated symptoms ED visits Daily use of analgesics How the headache started? History upon Detailed Questioning Two types of headache Constant pressure Can have Spikes of severe pain lasting for hours Constant headache Mild to moderate intensity Acetaminophen takes the edge but it returns 2

History upon Detailed Questioning Episodic pain Similar headache in childhood High severity and sometimes can lead to ED visits 2-3 times per week Throbbing pain, usually unilateral temporal but can be bilateral Nausea and photophobia Diagnosis Episodic Migraine & Medication Overuse Headache Chronic Daily Headache (CDH) A spectrum of headaches Headache lasting more than three months Chronic = more days than not in a month Most common types; Chronic tension-type headache Chronic migraine Medication overuse headache (MOH) Tension-Type Headache (TTH) Most common from of headache Overdiagnosed Based on what is it not Classified into: Classified into: Infrequent episodic TTH Frequent episodic TTH Chronic TTH Probable TTH 3

Chronic TTH (ICHD-II) Description of Episodic TTH A disorder evolving from episodic tension-type headache, with daily or very frequent episodes of headache lasting minutes to days. The pain is typically bilateral, pressing or tightening in quality and of mild to moderate intensity, it and it does not worsen with routine physical activity. There may be mild nausea, photophobia or phonophobia. Chronic TTH (ICHD-II) Diagnostic criteria A. Headache occurring on 15 days per month on average for >3 months ( 180 days per year) and fulfilling criteria B-D B. Headache lasts hours or may be continuous C. Headache has at least two of the following characteristics: 1. bilateral location 2. pressing/tightening (non-pulsating) quality 3. mild or moderate intensity 4. not aggravated by routine physical activity such as walking or climbing stairs D. Both of the following: 1. no more than one of photophobia, phonophobia or mild nausea 2. neither moderate or severe nausea nor vomiting E. Not attributed to another disorder Treatment & Prognosis Non-Pharmacological treatment Biofeedback Acupuncture, relaxation, physical therapy Pharmacological treatment Acute (simple analgesics) Preventive (Antidepressants) Favorable prognosis Prevalence of Migraine 17.6% 18.2% 17.1% 12.1% 12.6% AMS-I 11.7% AMS-II 5.7% 6.5% 5.6% All Female Male AMPP Lipton 2007 4

Migraine is Underdiagnosed and Undertreated 48% MD Diagnosis 49% 23% 23% RX Medication OTC Medication Both RX and OTC 5% No Medication Economic Burden of Migraine Total Cost of Migraine > $ 14 Billion Direct Medical Cost > $ 1 Billion Office visits Inpatient visits ER visits Indirect Medical Cost > $ 13 Billion Missed workdays Loss of productivity Direct Cost Indirect Cost 93% 7% Lipton 2001 Hu et al, 1999 Migraine: Diagnostic Criteria (ICHD-II) Description: Recurrent headache disorder manifesting in attacks lasting 4-72 hours. Typical characteristics of the headache are unilateral location, pulsating quality, moderate or severe e e intensity, ty, aggravation a at by routine physical activity and association with nausea and/or photophobia and phonophobia Migraine: Diagnostic Criteria (ICHD-II) Diagnostic criteria A. At least 5 attacks fulfilling criteria B-D B. Headache attacks lasting 4-72 hours (untreated or unsuccessfully treated) C. Headache has at least two of the following characteristics: unilateral location pulsating quality moderate or severe pain intensity aggravation by or causing avoidance of routine physical activity (eg, walking or climbing stairs) D. During headache at least one of the following: nausea and/or vomiting photophobia and phonophobia E. Not attributed to another disorder 5

Migraine Classification (ICHD-II) 1. Migraine without aura 2. Migraine with aura a. Typical aura with migraine headache b. Typical aura with non-migraine headache c. Typical aura without a headache d. Familial hemiplegic migraine (FHM) e. Sporadic hemiplegic migraine f. Basilar-type migraine 3. Childhood periodic syndromes that are commonly precursors of migraine a. Cyclical vomiting b. Abdominal migraine c. Benign paroxysmal vertigo of childhood Migraine Classification (ICHD-II) 4. Retinal migraine 5. Complications of Migraine a. Chronic migraine b. Status migrainosus c. Persistent aura without migraine d. Migranous infarction e. Migraine-triggered seizure 6. Probable migraine Diagnosing Migraine Consider any episodic headache a migraine May use the 3-item ID Migraine Screener Disability, nausea, photophobia h (PPV 0.93) Lipton 2003 Consider a therapeutic trial of a triptan Pitfalls of Migraine Diagnosis Migraine is misdiagnosed as episodic tension-type headache (TTH) Migraine is misdiagnosed as sinus headache Not recognizing transformed migraine or MOH 6

Pitfalls- Episodic TTH Spectrum Study 32% who were initially diagnosed to have episodic TTH were determined to have migraine Lipton 2002 Episodic TTH is over diagnosed THH lacks distinctive features (migraine requires positive features) Neck pain reported in migraine (61% prodrome, 92% headache, 41% postdrome) Both conditions share symptoms, epidemiology, precipitants, and response to treatment single entity with different severity Two separate disorders Kaniecki 2002 Pitfalls- Sinus Headache Episodic Sinus headache is rare Sinus pressure and sinus pain are misleading (not uncommon in migraine) In 2991 patients with sinus headache, 88% had migraines (ICHD) Schreiber 2004 Sumatriptan helped to relieve headache and sinus pain more than placebo in patients with sinus headache Ishkanina 2007 Migraine Treatment Non-pharmacological Triggers, sleep, schedule Pharmacological Abortive Treatment Triptans Preventive treatment Decreases frequency and severity More responsive to abortive treatment Indicated when migraine frequency is high Considered if frequency is not high Aura without a headache Migraines not responding to abortive treatment Pitfalls of Migraine Treatment Abortive Treatment Failure to tell patients to use treatment at onset Triptans Failure to recognize the proper p administration route Not giving sufficient trials Not preventing medication overuse headache Not having a plan B Preventive Treatment Lack of proper instructions 7

Medication Overuse Headache (MOH) The headache patients and treating professionals create Other terminology: Analgesic rebound Headache Medication induced headache Analgesic induced headache Medication Overuse Headache (ICHD-II) Diagnostic criteria: A. Headache present on 15 days/month fulfilling criteria C and D B. Regular overuse for 3 months of one or more drugs that can be taken for acute and/or symptomatic treatment of headache C. Headache has developed or markedly worsened during medication overuse D. Headache resolves or reverts to its previous pattern within 2 months after discontinuation of overused medication Medication Overuse Headache (MOH) Prevalence is 0.7-1.7% Up to 20% of chronic headaches Usually in patients with episodic migraine (transformed migraine) Many patients with chronic migraine have it Medication Overuse Headache (MOH) Pathophysiology is not clear Any as needed analgesic can cause it used 2-3 times per week Symptoms shifting, even within the same day, from migraine-like to those of tensiontype headache. Missed frequently HCPs do not evaluate for it OTCs are not considered medications 8

Management of MOH Education Stopping the offending agent Gradual Abrupt Provide acute treatment (bridging) Offer preventive treatment for the underlying episodic migraine Best treatment is prevention Alternate analgesics Summary Chronic Daily Headache is spectrum of headaches Detailed history is a key in evaluating CDH Preventing MOH is a key in dealing with CDH Triptans: Role of neuroimaging Sumatriptan (Imitrex) Zolmitriptan (Zomig) El t i t (R l ) Eletriptan (Relpax) Naratriptan (Amerge) Rizatriptan (Maxalt) Almotriptan (Axert) Frovatriptan (Frova) 9

Preventative medications for migraine Tricyclic antidepressants Beta blockers Calcium channel blockers Anticonvulsants Headache centers Case #1 Case #2 18 year old woman College freshman 3 month history of left-sided headaches lasting 4 hours occurring every 2-3 weeks Visual sensation of wavy lights precedes headaches Frequently accompanied by vomiting 23 year old man Intense retro-orbital right sided headache O d il i id ft Occurs daily in mid-afternoon No aura; rapid onset of pain Unilateral rhinitis and lacrimation Similar bout of headaches lasted 3 weeks last year 10

Case #3 Case #4 50 year old man recently moved to the community Beginning in November, daily morning headaches that improve during the day Some dizziness and mild confusion Wife now reporting similar symptoms 48 year old government administrator Migraines for 20 years He has used many preventive and abortive medications without good response Now worse and he wants disability Case #5 Case #6 50 year old executive Headaches on weekends only Feels fine during the week Also had daily headaches when on vacation recently 70 year old woman Progressively severe daily headache for three weeks Now having nausea and frequent falls No previous headache history 11

Case #7 28 year old man presents to the emergency department with severe headache, nausea, and vomiting Long history of migraine headaches 12